DUOTOL AB has a total of 27 patent applications. Its first patent ever was published in 1994. It filed its patents most often in United States, Canada and Australia. Its main competitors in its focus markets pharmaceuticals, machines and biotechnology are ILEX ONCOLOGY INC, IMMUNOLYTICS INC and SANTOSOLVE AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Canada | 5 | |
#3 | Australia | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | China | 2 | |
#6 | Republic of Korea | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Biotechnology | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Unspecified technologies | |
#4 | Climate change adaptation technologies | |
#5 | Microorganisms | |
#6 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Holmgren Jan | 24 |
#2 | Czerkinsky Cecil | 16 |
#3 | Harandi Ali M | 6 |
#4 | Erikssen Kristina | 3 |
#5 | Jan Holmgren | 1 |
#6 | Harandi Ali | 1 |
#7 | Holmgren Jan R | 1 |
Publication | Filing date | Title |
---|---|---|
CA2601358A1 | Method for inducing mucosal humoral and cell-mediated immune responses by sublingual administration of antigens | |
US2008112974A1 | Method for inducing mucosal humoral and cell-mediated immune responses by sublingual administration of antigens | |
AU2003241251A1 | Biofunctional CpG or oligo-/polynucleotide and toxin or enterotoxin containing composition | |
US2005074462A1 | Supression of allergic reactions by transdermal administration of allergens conjugated to cholera toxin or fragments thereof | |
WO03006055A2 | Methods for promoting antigen presentation and modulating immune responses using cholera toxin and its b subunit | |
US6153203A | Immunological tolerance-inducing agent | |
US5681571A | Immunological tolerance-inducing agent |